STML - Stemline Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts6665
Avg. Estimate-0.35-0.32-1.28-0.79
Low Estimate-0.4-0.45-1.54-1.37
High Estimate-0.26-0.13-0.780.11
Year Ago EPS-0.42-0.34-1.83-1.28
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts6665
Avg. Estimate12.5M14.89M57.76M95.85M
Low Estimate9M5M41.82M70M
High Estimate15.29M22.93M76.44M133.63M
Year Ago SalesN/A13.33M43.22M57.76M
Sales Growth (year/est)N/A11.70%33.70%65.90%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.56-0.45-0.35-0.36
EPS Actual-0.42-0.34-0.38-0.45
Difference0.140.11-0.03-0.09
Surprise %25.00%24.40%-8.60%-25.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.35-0.32-1.28-0.79
7 Days Ago-0.35-0.32-1.28-0.79
30 Days Ago-0.36-0.33-1.34-0.85
60 Days Ago-0.35-0.33-1.32-0.85
90 Days Ago-0.34-0.33-1.31-0.83
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesSTMLIndustrySectorS&P 500
Current Qtr.16.70%N/AN/AN/A
Next Qtr.5.90%N/AN/AN/A
Current Year30.10%N/AN/AN/A
Next Year38.30%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A